Regencell Bioscience Holdings Ltd
RGC16.810USD
-1.630-8.84%
Close 10/10, 16:00（ET）Quotes delayed by 15 min
8.31BMarket Cap
--P/E TTM
More Details of Regencell Bioscience Holdings Ltd Company
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
Regencell Bioscience Holdings Ltd Info
Ticker SymbolRGC
Company nameRegencell Bioscience Holdings Ltd
IPO dateJul 16, 2021
CEO- -
Number of employees12
Security typeOrdinary Share
Fiscal year-endJul 16
Address11/F, First Commercial Building, 33-35 Leighton Road, Causeway Bay
City
Stock exchangeNASDAQ Capital Market Consolidated
CountryHong Kong
Postal code- -
Phone85221550823
Websitehttps://www.regencellbioscience.com/
Ticker SymbolRGC
IPO dateJul 16, 2021
CEO- -
Company Executives of Regencell Bioscience Holdings Ltd
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Tue, Oct 7
Updated: Tue, Oct 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Au (Yat-Gai)
88.56%
Digital Mobile Venture, Ltd.
7.60%
Geode Capital Management, L.L.C.
0.08%
Squarepoint Capital LLP
0.02%
Schonfeld Strategic Advisors LLC
0.01%
Other
3.74%
Shareholders
Shareholders
Proportion
Au (Yat-Gai)
88.56%
Digital Mobile Venture, Ltd.
7.60%
Geode Capital Management, L.L.C.
0.08%
Squarepoint Capital LLP
0.02%
Schonfeld Strategic Advisors LLC
0.01%
Other
3.74%
Shareholder Types
Shareholders
Proportion
Individual Investor
88.56%
Corporation
7.60%
Investment Advisor/Hedge Fund
0.10%
Research Firm
0.02%
Investment Advisor
0.01%
Hedge Fund
0.01%
Other
3.71%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
20
680.91K
0.14%
+333.30K
2025Q2
15
464.50M
93.94%
+23.83M
2025Q1
12
464.34M
93.90%
+23.68M
2024Q4
10
11.60M
89.11%
+20.25K
2024Q3
10
11.58M
89.01%
+24.37K
2024Q2
11
11.57M
88.87%
+5.63K
2024Q1
12
11.56M
88.83%
-17.42K
2023Q4
12
11.57M
88.94%
+13.30K
2023Q3
13
11.56M
88.82%
-12.42K
2023Q2
13
11.55M
88.77%
-36.88K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Au (Yat-Gai)
437.90M
88.56%
+11.47M
+2.69%
Jul 11, 2025
Digital Mobile Venture, Ltd.
37.58M
7.6%
--
--
Jun 30, 2024
Geode Capital Management, L.L.C.
391.07K
0.08%
+132.06K
+50.99%
Jun 30, 2025
Squarepoint Capital LLP
99.84K
0.02%
+99.84K
--
Jun 30, 2025
Schonfeld Strategic Advisors LLC
52.10K
0.01%
+52.10K
--
Jun 30, 2025
BNP Paribas Securities Corp. North America
45.05K
0.01%
+45.05K
--
Jun 30, 2025
UBS Financial Services, Inc.
37.53K
0.01%
+37.53K
--
Jun 30, 2025
Morgan Stanley & Co. LLC
32.42K
0.01%
+32.23K
+16965.79%
Jun 30, 2025
Y-Intercept (Hong Kong) Ltd
13.04K
0%
+13.04K
--
Jun 30, 2025
BlackRock Financial Management, Inc.
4.87K
0%
-4.18K
-46.21%
Jun 30, 2025
View more
Related ETFs
Updated: Mon, Oct 6
Updated: Mon, Oct 6
Name
Proportion
Fidelity Nasdaq Composite Index ETF
0.02%
Fidelity Nasdaq Composite Index ETF
Proportion0.02%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
